Follow
Lisa Connolly
Lisa Connolly
Professor in Toxin Food Safety, Queen's University Belfast
Verified email at qub.ac.uk
Title
Cited by
Cited by
Year
Endocrine disrupting effects of zearalenone, alpha-and beta-zearalenol at the level of nuclear receptor binding and steroidogenesis
C Frizzell, D Ndossi, S Verhaegen, E Dahl, G Eriksen, M Sørlie, ...
Toxicology letters 206 (2), 210-217, 2011
2372011
Effect of Inhibitor Compounds on Nε-(Carboxymethyl)lysine (CML) and Nε-(Carboxyethyl)lysine (CEL) Formation in Model Foods
C Srey, GLJ Hull, L Connolly, CT Elliott, MD del Castillo, JM Ames
Journal of Agricultural and Food Chemistry 58 (22), 12036-12041, 2010
1182010
Expression of multidrug resistance markers ABCB1 (MDR-1/P-gp) and ABCC1 (MRP-1) in renal cell carcinoma
N Walsh, A Larkin, S Kennedy, L Connolly, J Ballot, W Ooi, G Gullo, ...
BMC urology 9, 1-7, 2009
1142009
Potential adverse effects on animal health and performance caused by the addition of mineral adsorbents to feeds to reduce mycotoxin exposure
CT Elliott, L Connolly, O Kolawole
Mycotoxin Research 36 (1), 115-126, 2020
1012020
Obesity II: Establishing causal links between chemical exposures and obesity
JJ Heindel, S Howard, K Agay-Shay, JP Arrebola, K Audouze, PJ Babin, ...
Biochemical pharmacology 199, 115015, 2022
872022
Selection with melphalan or paclitaxel (Taxol) yields variants with different patterns of multidrug resistance, integrin expression and in vitro invasiveness
Y Liang, P Meleady, I Cleary, S McDonnell, L Connolly, M Clynes
European journal of cancer 37 (8), 1041-1052, 2001
832001
An in vitro investigation of endocrine disrupting effects of the mycotoxin alternariol
C Frizzell, D Ndossi, S Kalayou, GS Eriksen, S Verhaegen, M Sørlie, ...
Toxicology and applied pharmacology 271 (1), 64-71, 2013
802013
Endocrine disruptor activity of multiple environmental food chain contaminants
E Wielogorska, CT Elliott, M Danaher, L Connolly
Toxicology in vitro 29 (1), 211-220, 2015
792015
An in vitro investigation of endocrine disrupting effects of trichothecenes deoxynivalenol (DON), T-2 and HT-2 toxins
DG Ndossi, C Frizzell, NH Tremoen, CK Fæste, S Verhaegen, E Dahl, ...
Toxicology letters 214 (3), 268-278, 2012
732012
Endocrine disruptor activity in bottled mineral and flavoured water
M Plotan, C Frizzell, V Robinson, CT Elliott, L Connolly
Food Chemistry 136 (3-4), 1590-1596, 2013
702013
Cytotoxic assessment of the regulated, co-existing mycotoxins aflatoxin B1, fumonisin B1 and ochratoxin, in single, binary and tertiary mixtures
R Clarke, L Connolly, C Frizzell, CT Elliott
Toxicon 90, 70-81, 2014
682014
Development of a monoclonal antibody binding okadaic acid and dinophysistoxins-1,-2 in proportion to their toxicity equivalence factors
LD Stewart, CT Elliott, AD Walker, RM Curran, L Connolly
Toxicon 54 (4), 491-498, 2009
672009
Biotransformation of zearalenone and zearalenols to their major glucuronide metabolites reduces estrogenic activity
C Frizzell, S Uhlig, CO Miles, S Verhaegen, CT Elliott, GS Eriksen, ...
Toxicology In Vitro 29 (3), 575-581, 2015
662015
Estrogenic endocrine disruptors present in sports supplements. A risk assessment for human health
M Plotan, CT Elliott, C Frizzell, L Connolly
Food chemistry 159, 157-165, 2014
612014
Treatment of estrogens and androgens in dairy wastewater by a constructed wetland system
K Cai, CT Elliott, DH Phillips, ML Scippo, M Muller, L Connolly
Water research 46 (7), 2333-2343, 2012
602012
Effects of defined mixtures of persistent organic pollutants (POPs) on multiple cellular responses in the human hepatocarcinoma cell line, HepG2, using high content analysis …
J Wilson, HF Berntsen, KE Zimmer, C Frizzell, S Verhaegen, E Ropstad, ...
Toxicology and applied pharmacology 294, 21-31, 2016
582016
In vitro bioassays for the study of endocrine-disrupting food additives and contaminants
L Connolly, E Ropstad, S Verhaegen
TrAC Trends in Analytical Chemistry 30 (2), 227-238, 2011
572011
Development and single-laboratory validation of a pseudofunctional biosensor immunoassay for the detection of the okadaic acid group of toxins
LD Stewart, P Hess, L Connolly, CT Elliott
Analytical chemistry 81 (24), 10208-10214, 2009
562009
Endocrine disrupting effects of ochratoxin A at the level of nuclear receptor activation and steroidogenesis
C Frizzell, S Verhaegen, E Ropstad, CT Elliott, L Connolly
Toxicology letters 217 (3), 243-250, 2013
482013
Increased anti-tumour efficacy of doxorubicin when combined with sulindac in a xenograft model of an MRP-1-positive human lung cancer
R O'CONNOR, M Heenan, L Connolly, A Larkin, M Clynes
Anticancer research 24 (2A), 457-464, 2004
482004
The system can't perform the operation now. Try again later.
Articles 1–20